Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 15, 2019 - Issue 3
Submit an article Journal homepage
927
Views
1
CrossRef citations to date
0
Altmetric
Reply Letter

Comment on Gomez et. al. “Response to article by Wasserman et. al. (2018) ‘Modelling the sustained use of the 13-valent pneumococcal conjugate vaccine compared to switching to the 10-valent vaccine in Mexico’”

Matt WassermanHealth Economics and Outcomes Research, Pfizer Inc, New York, NY, USACorrespondence[email protected]
,
Maria Gabriela PalaciosMedical and Scientific Affairs, Pfizer Inc., Mexico City, Mexico
,
Ana Gabriela GrajalesMedical and Scientific Affairs, Pfizer Inc., Mexico City, Mexico
,
Michele WilsonRTI Health Solutions, Research Triangle Park, NC, USA
,
Cheryl McDadeRTI Health Solutions, Research Triangle Park, NC, USA
&
Raymond FarkouhHealth Economics and Outcomes Research, Pfizer Inc, Collegeville, PA, USA
Pages 572-574 | Received 03 Dec 2018, Accepted 03 Dec 2018, Published online: 18 Jan 2019

Figures & data

This paper does not have figures.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.